Journal of Comparative Effectiveness Research

The latest CER, RWE & HEOR for patients, researchers, policy makers & all stakeholders | IF: 2.5 | MEDLINE-indexed | from Becaris Publishing

[The Evidence Base @TheEviBase]

Webinar: Beyond borders - The global policy forces transforming #pharma pricing and #marketaccess - https://t.co/IJEaKGPcbO

[The Evidence Base @TheEviBase]

Connecting real-world datasets to provide deeper insights into the patient journey | @cardinalhealth https://t.co/ZrwmjraHj5

[The Evidence Base @TheEviBase]

Patti's People - Patti Peeples speaks with Paul Scuffham | Becaris Publishing https://t.co/XP4CFMrVpZ

[Journal of Comparative Effectiveness Research @Journal_CER]

From potential to practice: Global considerations for #AI in health system decision-making | @Certara @NestedKnowledge #isporeurope https://t.co/VhgvyWZWdy

[The Evidence Base @TheEviBase]

Lessons from a pilot study on AI coding and analysis of qualitative patient data | Becaris Publishing https://t.co/frivYoMuNv

[The Evidence Base @TheEviBase]

What makes evidence matter? Examining the real-world evidence decision paradox | https://t.co/eu4cGjPRyj

[The Evidence Base @TheEviBase]

Most-favored nation pricing: Updates and strategic insights from Tim Wright, Genesis Research Group https://t.co/DCsQlr7KMi

[The Evidence Base @TheEviBase]

Lessons from a pilot study on #AI coding and analysis of qualitative patient data | @thermofisher https://t.co/frivYoLWXX

[The Evidence Base @TheEviBase]

From potential to practice: Global considerations for #AI in health system decision-making | @Certara @NestedKnowledge #ISPOREurope https://t.co/jzyjxQYEJC

[The Evidence Base @TheEviBase]

Most-favored nation pricing: Updates and strategic insights from Tim Wright, Genesis Research Group https://t.co/DCsQlr8iBQ

[The Evidence Base @TheEviBase]

How #AI-assisted screening can improve efficiency and accuracy in targeted literature reviews | @thermofisher https://t.co/CG1RBrdJdJ

[The Evidence Base @TheEviBase]

Beyond borders: The global policy forces transforming pharma pricing and market access https://t.co/IJEaKGPK1m

[The Evidence Base @TheEviBase]

Preparing effective systematic literature reviews and indirect treatment comparisons for joint clinical assessment (JCA) | @thermofisher #ISPOREurope https://t.co/da8hfWexij

[The Evidence Base @TheEviBase]

Overcoming barriers to cell and gene therapy adoption with #realworldevidence | @thermofisher https://t.co/D23bGpN4xa

[The Evidence Base @TheEviBase]

What makes evidence matter? Examining the #realworldevidence decision paradox | https://t.co/eu4cGjPjIL

[The Evidence Base @TheEviBase]

WEBINAR - Beyond borders: The global policy forces transforming pharma pricing and market access https://t.co/IJEaKGPcbO

[The Evidence Base @TheEviBase]

Overcoming barriers to cell and gene therapy adoption with #realworldevidence | @thermofisher https://t.co/D23bGpNCmI

[The Evidence Base @TheEviBase]

Lessons from a pilot study on #AI coding and analysis of qualitative patient data | @thermofisher #ISPOREurope https://t.co/frivYoLWXX

[The Evidence Base @TheEviBase]

Rethinking global pricing strategies through the #mostfavorednation lens | #ISPOREurope https://t.co/IXgvFcJdko

[The Evidence Base @TheEviBase]

Accelerating #JCA readiness with an #AI-enabled framework for early #PICO identification | @Certara https://t.co/bxUwvGSRjE